Selected research
Market Structure
Global Adult Antipyretics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Adult Antipyretics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Adult Antipyretics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Adult Antipyretics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Adult Antipyretics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Adult Antipyretics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Adult Antipyretics include Anqiu Lu'an, Atabay, Farmson, Granules Biocause, Granules India, IOLCP, Mallinckrodt, Novacyl and SKPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Adult Antipyretics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Adult Antipyretics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Adult Antipyretics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Adult Antipyretics market size, projected growth trends, production technologies, key applications, and end-use industries.
Adult Antipyretics Segment by Company
Anqiu Lu'an
Atabay
Farmson
Granules Biocause
Granules India
IOLCP
Mallinckrodt
Novacyl
SKPL
Strides Shasun
Temad
Anhui BBCA Likang
Anhui Fubore
Changshu Huagang
Hebei Jiheng
Xinhua Pharmaceutical
Zhejiang Kangle
Adult Antipyretics Segment by Type
Acetaminophen
Ibuprofen
Other
Adult Antipyretics Segment by Application
Online Sales
Offline Sales
Adult Antipyretics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult Antipyretics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult Antipyretics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult Antipyretics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Adult Antipyretics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adult Antipyretics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adult Antipyretics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Adult Antipyretics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Acetaminophen
- Ibuprofen
- Other
Applications
- Online Sales
- Offline Sales
Companies covered
- Anqiu Lu'an
- Atabay
- Farmson
- Granules Biocause
- Granules India
- IOLCP
- Mallinckrodt
- Novacyl
- SKPL
- Strides Shasun
- Temad
- Anhui BBCA Likang
- Anhui Fubore
- Changshu Huagang
- Hebei Jiheng
- Xinhua Pharmaceutical
- Zhejiang Kangle
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Adult Antipyretics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Adult Antipyretics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Adult Antipyretics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Adult Antipyretics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Adult Antipyretics Market Dynamics
- 2.1 Adult Antipyretics Industry Trends
- 2.2 Adult Antipyretics Industry Drivers
- 2.3 Adult Antipyretics Industry Opportunities and Challenges
- 2.4 Adult Antipyretics Industry Restraints
3 Adult Antipyretics Market by Manufacturers
- 3.1 Global Adult Antipyretics Revenue by Manufacturers (2021-2026)
- 3.2 Global Adult Antipyretics Sales by Manufacturers (2021-2026)
- 3.3 Global Adult Antipyretics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Adult Antipyretics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Adult Antipyretics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Adult Antipyretics Manufacturers, Product Type & Application
- 3.7 Global Adult Antipyretics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Adult Antipyretics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Adult Antipyretics Players Market Share by Revenue in 2025
- 3.8.3 2025 Adult Antipyretics Tier 1, Tier 2, and Tier 3
4 Adult Antipyretics Market by Type
- 4.1 Adult Antipyretics Type Introduction
- 4.1.1 Acetaminophen
- 4.1.2 Ibuprofen
- 4.1.3 Other
- 4.2 Global Adult Antipyretics Sales by Type
- 4.2.1 Global Adult Antipyretics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Adult Antipyretics Sales by Type (2021-2032)
- 4.2.3 Global Adult Antipyretics Sales Market Share by Type (2021-2032)
- 4.3 Global Adult Antipyretics Revenue by Type
- 4.3.1 Global Adult Antipyretics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Adult Antipyretics Revenue by Type (2021-2032)
- 4.3.3 Global Adult Antipyretics Revenue Market Share by Type (2021-2032)
5 Adult Antipyretics Market by Application
- 5.1 Adult Antipyretics Application Introduction
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Adult Antipyretics Sales by Application
- 5.2.1 Global Adult Antipyretics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Adult Antipyretics Sales by Application (2021-2032)
- 5.2.3 Global Adult Antipyretics Sales Market Share by Application (2021-2032)
- 5.3 Global Adult Antipyretics Revenue by Application
- 5.3.1 Global Adult Antipyretics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Adult Antipyretics Revenue by Application (2021-2032)
- 5.3.3 Global Adult Antipyretics Revenue Market Share by Application (2021-2032)
6 Global Adult Antipyretics Sales by Region
- 6.1 Global Adult Antipyretics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Adult Antipyretics Sales by Region (2021-2032)
- 6.2.1 Global Adult Antipyretics Sales by Region (2021-2026)
- 6.2.2 Global Adult Antipyretics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Adult Antipyretics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Adult Antipyretics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Adult Antipyretics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Adult Antipyretics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Adult Antipyretics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Adult Antipyretics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Adult Antipyretics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Adult Antipyretics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Adult Antipyretics Revenue by Region
- 7.1 Global Adult Antipyretics Revenue by Region
- 7.1.1 Global Adult Antipyretics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Adult Antipyretics Revenue by Region (2021-2026)
- 7.1.3 Global Adult Antipyretics Revenue by Region (2027-2032)
- 7.1.4 Global Adult Antipyretics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Adult Antipyretics Revenue (2021-2032)
- 7.2.2 North America Adult Antipyretics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Adult Antipyretics Revenue (2021-2032)
- 7.3.2 Europe Adult Antipyretics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Adult Antipyretics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Adult Antipyretics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Adult Antipyretics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Adult Antipyretics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Anqiu Lu'an
- 8.1.1 Anqiu Lu'an Company Information
- 8.1.2 Anqiu Lu'an Business Overview
- 8.1.3 Anqiu Lu'an Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Anqiu Lu'an Adult Antipyretics Product Portfolio
- 8.1.5 Anqiu Lu'an Recent Developments
- 8.2 Atabay
- 8.2.1 Atabay Company Information
- 8.2.2 Atabay Business Overview
- 8.2.3 Atabay Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Atabay Adult Antipyretics Product Portfolio
- 8.2.5 Atabay Recent Developments
- 8.3 Farmson
- 8.3.1 Farmson Company Information
- 8.3.2 Farmson Business Overview
- 8.3.3 Farmson Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Farmson Adult Antipyretics Product Portfolio
- 8.3.5 Farmson Recent Developments
- 8.4 Granules Biocause
- 8.4.1 Granules Biocause Company Information
- 8.4.2 Granules Biocause Business Overview
- 8.4.3 Granules Biocause Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Granules Biocause Adult Antipyretics Product Portfolio
- 8.4.5 Granules Biocause Recent Developments
- 8.5 Granules India
- 8.5.1 Granules India Company Information
- 8.5.2 Granules India Business Overview
- 8.5.3 Granules India Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Granules India Adult Antipyretics Product Portfolio
- 8.5.5 Granules India Recent Developments
- 8.6 IOLCP
- 8.6.1 IOLCP Company Information
- 8.6.2 IOLCP Business Overview
- 8.6.3 IOLCP Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 IOLCP Adult Antipyretics Product Portfolio
- 8.6.5 IOLCP Recent Developments
- 8.7 Mallinckrodt
- 8.7.1 Mallinckrodt Company Information
- 8.7.2 Mallinckrodt Business Overview
- 8.7.3 Mallinckrodt Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Mallinckrodt Adult Antipyretics Product Portfolio
- 8.7.5 Mallinckrodt Recent Developments
- 8.8 Novacyl
- 8.8.1 Novacyl Company Information
- 8.8.2 Novacyl Business Overview
- 8.8.3 Novacyl Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Novacyl Adult Antipyretics Product Portfolio
- 8.8.5 Novacyl Recent Developments
- 8.9 SKPL
- 8.9.1 SKPL Company Information
- 8.9.2 SKPL Business Overview
- 8.9.3 SKPL Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 SKPL Adult Antipyretics Product Portfolio
- 8.9.5 SKPL Recent Developments
- 8.10 Strides Shasun
- 8.10.1 Strides Shasun Company Information
- 8.10.2 Strides Shasun Business Overview
- 8.10.3 Strides Shasun Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Strides Shasun Adult Antipyretics Product Portfolio
- 8.10.5 Strides Shasun Recent Developments
- 8.11 Temad
- 8.11.1 Temad Company Information
- 8.11.2 Temad Business Overview
- 8.11.3 Temad Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Temad Adult Antipyretics Product Portfolio
- 8.11.5 Temad Recent Developments
- 8.12 Anhui BBCA Likang
- 8.12.1 Anhui BBCA Likang Company Information
- 8.12.2 Anhui BBCA Likang Business Overview
- 8.12.3 Anhui BBCA Likang Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Anhui BBCA Likang Adult Antipyretics Product Portfolio
- 8.12.5 Anhui BBCA Likang Recent Developments
- 8.13 Anhui Fubore
- 8.13.1 Anhui Fubore Company Information
- 8.13.2 Anhui Fubore Business Overview
- 8.13.3 Anhui Fubore Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Anhui Fubore Adult Antipyretics Product Portfolio
- 8.13.5 Anhui Fubore Recent Developments
- 8.14 Changshu Huagang
- 8.14.1 Changshu Huagang Company Information
- 8.14.2 Changshu Huagang Business Overview
- 8.14.3 Changshu Huagang Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Changshu Huagang Adult Antipyretics Product Portfolio
- 8.14.5 Changshu Huagang Recent Developments
- 8.15 Hebei Jiheng
- 8.15.1 Hebei Jiheng Company Information
- 8.15.2 Hebei Jiheng Business Overview
- 8.15.3 Hebei Jiheng Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Hebei Jiheng Adult Antipyretics Product Portfolio
- 8.15.5 Hebei Jiheng Recent Developments
- 8.16 Xinhua Pharmaceutical
- 8.16.1 Xinhua Pharmaceutical Company Information
- 8.16.2 Xinhua Pharmaceutical Business Overview
- 8.16.3 Xinhua Pharmaceutical Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Xinhua Pharmaceutical Adult Antipyretics Product Portfolio
- 8.16.5 Xinhua Pharmaceutical Recent Developments
- 8.17 Zhejiang Kangle
- 8.17.1 Zhejiang Kangle Company Information
- 8.17.2 Zhejiang Kangle Business Overview
- 8.17.3 Zhejiang Kangle Adult Antipyretics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Zhejiang Kangle Adult Antipyretics Product Portfolio
- 8.17.5 Zhejiang Kangle Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Adult Antipyretics Value Chain Analysis
- 9.1.1 Adult Antipyretics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Adult Antipyretics Production Mode & Process
- 9.2 Adult Antipyretics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Adult Antipyretics Distributors
- 9.2.3 Adult Antipyretics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst